<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04813952</url>
  </required_header>
  <id_info>
    <org_study_id>1019</org_study_id>
    <nct_id>NCT04813952</nct_id>
  </id_info>
  <brief_title>The Effect of Minimal Flow Sevoflurane Anesthesia</brief_title>
  <official_title>The Effect of Minimal Flow Sevoflurane Anesthesia on Blood Gas Analysis and Hemodynamic Parameters in Laparoscopic Cholecystectomies, a Randomised Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Hamidiye Etfal Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Hamidiye Etfal Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim is to investigate the effect of minimal flow anesthesia with sevoflurane on&#xD;
      hemodynamics and arterial blood gas parameters in laparoscopic cholecystectomy operations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Low-flow anesthesia techniques have regained popularity in recent years with&#xD;
      the development of low solubility volatile agents such as sevoflurane and desflurane, and&#xD;
      modern anesthesia devices. Reducing the flow of fresh gas as much as possible will reduce the&#xD;
      amount of volatile agent used, thus preventing air pollution, providing lower costs, and also&#xD;
      preserving heat and moisture in the respiratory tract by using rebreathing systems.&#xD;
      Laparoscopic surgery is superior to open surgical techniques due to its minimally invasive&#xD;
      nature, less postoperative pain, less incidence of wound infections, shortening the&#xD;
      hospitalization, and allowing patients to return to their normal lives sooner after the&#xD;
      operation.&#xD;
&#xD;
      Our aim is to investigate the effect of minimal flow anesthesia with sevoflurane on&#xD;
      hemodynamics and arterial blood gas parameters in laparoscopic cholecystectomy operations.&#xD;
&#xD;
      Material and Method: Seventy patients with ASA (American Society of Anesthesiologists) class&#xD;
      I-II between the ages of 18-65 undergoing elective laparoscopic cholecystectomy were included&#xD;
      in the study. After the patients were randomly selected by computer, they were divided into&#xD;
      two equal groups as Group M (minimal flow anesthesia group) with fresh gas flow 0,5 L.min-1&#xD;
      and Group C (high flow anesthesia/ control group) with fresh gas flow 4 L.min-1. In both&#xD;
      groups. Demographic data, duration of anesthesia, operation times, recovery times,&#xD;
      hemodynamic parameters and arterial blood gas parameters of all patients were recorded. The&#xD;
      patient data collected in both groups were compared statistically.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Actual">May 10, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>they will divided into two equal groups as Group M (minimal flow anesthesia group) with fresh gas flow 0,5 L.min-1 and Group C (high flow anesthesia/ control group) with fresh gas flow 4 L.min-1.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CHANGE IN P/F</measure>
    <time_frame>from the beginning to the end of anesthesia</time_frame>
    <description>PaO2/FiO2 ratio is the ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fractional inspired oxygen (FiO2 expressed as a fraction, not a percentage). P/F ratio is a widely used clinical indicator of hypoxaemia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CHANGE IN PaCO2</measure>
    <time_frame>from the beginning to the end of anesthesia</time_frame>
    <description>The partial pressure of carbon dioxide is the measure of carbon dioxide within arterial blood.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>volatile agent consumption amount</measure>
    <time_frame>from the beginning to the end of anesthesia</time_frame>
    <description>the total amount of volatile agent (sevoflurane) consumed at the end of the surgery</description>
  </secondary_outcome>
  <other_outcome>
    <measure>CHANGE IN HR</measure>
    <time_frame>from the beginning to the end of anesthesia</time_frame>
    <description>Heart rate per minute</description>
  </other_outcome>
  <other_outcome>
    <measure>CHANGE IN MAP</measure>
    <time_frame>from the beginning to the end of anesthesia</time_frame>
    <description>Mean arterial pressure</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Anesthesia; Functional</condition>
  <condition>Anesthesia Awareness</condition>
  <arm_group>
    <arm_group_label>Group M</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group M is minimal flow anesthesia group with fresh gas flow 0,5 L.min-1. Thirty five patients with ASA class I-II and between the ages of 18-65 undergoing elective laparoscopic cholecystectomy will be included. These patients were planned to be administered sevoflurane anesthesia with 0,5 L.min-1 flow under general anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group H</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group H is high flow anesthesia group with fresh gas flow 4 L.min-1. Thirty five patients with ASA class I-II and between the ages of 18-65 undergoing elective laparoscopic cholecystectomy will be included. These patients were planned to be administered sevoflurane anesthesia with 4 L.min-1 flow under general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane inhalant product</intervention_name>
    <description>The sevoflurane dose differed in both groups in relation to the fresh gas flow. Since the fresh gas flow is less in group M, the concentration of sevoflurane consumed by the patient at the end of the case will be less.</description>
    <arm_group_label>Group H</arm_group_label>
    <arm_group_label>Group M</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA (American Society of Anesthesiologists) class I-II&#xD;
&#xD;
          -  The operation time between 60-180 minutes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cardiac disease&#xD;
&#xD;
          -  COPD (Chronic Obstructive Pulmonary Disease)&#xD;
&#xD;
          -  Severe liver and kidney disease,&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Morbid obesity&#xD;
&#xD;
          -  Alcohol and/or drug addiction&#xD;
&#xD;
          -  Risk or history of malignant hyperthermia&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
&#xD;
          -  Emergency cases&#xD;
&#xD;
          -  Operation time less than 60 minutes and longer than 180 minutes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nurcan Coşkun</last_name>
    <role>Study Chair</role>
    <affiliation>Sisli Hamidiye Etfal Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serkan İslamoğlu</last_name>
    <role>Study Chair</role>
    <affiliation>Sisli Hamidiye Etfal Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nebia Peker</name>
      <address>
        <city>Şi̇şli̇</city>
        <state>Istanbul</state>
        <zip>34736</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/27413741/</url>
    <description>Effects of Low-Flow Sevoflurane Anesthesia on Pulmonary Functions in Patients Undergoing Laparoscopic Abdominal Surgery</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/23277809/</url>
    <description>The safety and efficacy of minimal-flow desflurane anesthesia during prolonged laparoscopic surgery</description>
  </link>
  <results_reference>
    <citation>Doger C, Kahveci K, Ornek D, But A, Aksoy M, Gokcinar D, Katar D. Effects of Low-Flow Sevoflurane Anesthesia on Pulmonary Functions in Patients Undergoing Laparoscopic Abdominal Surgery. Biomed Res Int. 2016;2016:3068467. doi: 10.1155/2016/3068467. Epub 2016 Jun 20.</citation>
    <PMID>27413741</PMID>
  </results_reference>
  <results_reference>
    <citation>Park SY, Chung CJ, Jang JH, Bae JY, Choi SR. The safety and efficacy of minimal-flow desflurane anesthesia during prolonged laparoscopic surgery. Korean J Anesthesiol. 2012 Dec;63(6):498-503. doi: 10.4097/kjae.2012.63.6.498. Epub 2012 Dec 14.</citation>
    <PMID>23277809</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>July 17, 2021</last_update_submitted>
  <last_update_submitted_qc>July 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Hamidiye Etfal Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Nebia Peker</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <keyword>minimal flow anesthesia</keyword>
  <keyword>laparoscopic cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intraoperative Awareness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

